M&A Deal Summary

Bausch Health Acquires Pedinol Pharmacal

On April 12, 2012, Bausch Health acquired life science company Pedinol Pharmacal

Acquisition Highlights
  • This is Bausch Health’s 13th transaction in the Life Science sector.
  • This is Bausch Health’s 8th transaction in the United States.
  • This is Bausch Health’s 1st transaction in New York.

M&A Deal Summary
Date 2012-04-12
Target Pedinol Pharmacal
Sector Life Science
Buyer(s) Bausch Health
Deal Type Add-on Acquisition

Target

Pedinol Pharmacal

Farmingdale, New York, United States
Pedinol Pharmacal, Inc. is a podiatry-focused, privately-owned specialty pharmaceutical company based in the US.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 19 of 35
Sector (Life Science) 13 of 21
Type (Add-on Acquisition) 12 of 25
State (New York) 1 of 3
Country (United States) 8 of 22
Year (2012) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-13 Gerot Lannach Holding

Austria

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-06-15 OraPharma

Horsham, Pennsylvania, United States

OraPharma, Inc. is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression.

Buy $312M
Mergr

Product

Company

Legal